Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation
详细信息 查看全文
- 作者：Bernhard Wernly ; Michael Lichtenauer ; Peter Jirak ; Sarah Eder ; Christian Reiter ; Jü ; rgen Kammler ; Alexander Kypta ; Christian Jung ; Marcus Franz ; Uta C. Hoppe ; Ulf Landmesser ; Hans-Reiner Figulla and Alexander Lauten
- 刊名：European Journal of Clinical Investigation
- 出版年：2017
- 出版时间：February 2017
- 年：2017
- 卷：47
- 期：2
- 页码：149-157
- 全文大小：122K
- ISSN：1365-2362
文摘
Soluble ST2 (sST2) has been introduced as a novel biomarker in patients suffering from heart failure for risk stratification. In this study, we sought to investigate whether sST2 is useful for risk stratification and prediction of mortality in patients undergoing transcatheter aortic valve implantation (TAVI).